Drug
Amphotericin B Liposome
Amphotericin B Liposome: highest development phase Phase 1, developed by Aurobindo. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Aurobindo
Trials
| Drug | Phase | Indication |
|---|---|---|
| Amphotericin B Liposome NCT03636659 | Phase 1 | Visceral Leishmaniasis |
Latest
No recent events.
Follow Amphotericin B Liposome on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.